Intrathecal therapy of leptomeningeal CEM T-cell lymphoma in nude rats with anti-CD7 ricin toxin A chain immunotoxin

Journal of Neuro-Oncology

Volumn 40, Issue 1, 1998, Pages 1-9

  Herrlinger, Ulrich ^a   Schmidberger, Heinz ^a   Buchholz, Rainer ^a   Wehrmann, Manfred ^a   Vallera, Daniel A ^b   Schabet, Martin ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

Author keywords

Animal model; Immunotherapy; Immunotoxin; Intrathecal therapy; Leptomeningeal metastasis; Lymphomatous meningitis

Indexed keywords

IMMUNOTOXIN; RICIN A; TRYPAN BLUE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BRAIN VENTRICLE; CELL INFILTRATION; CONTROLLED STUDY; EPENDYMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; INTRATHECAL DRUG ADMINISTRATION; LEPTOMENINX; METASTASIS; NONHUMAN; PARENCHYMA; RAT; SUBARACHNOID SPACE; SURVIVAL; T CELL LYMPHOMA; TUMOR CELL; WEIGHT GAIN;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD7; CYTOTOXICITY TESTS, IMMUNOLOGIC; DISEASE MODELS, ANIMAL; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOTHERAPY; IMMUNOTOXINS; INJECTIONS, SPINAL; LEUKEMIC INFILTRATION; LYMPHOMA, T-CELL; MENINGES; NEOPLASM TRANSPLANTATION; RATS; RATS, NUDE; RICIN; SURVIVAL ANALYSIS; TUMOR CELLS, CULTURED;

EID: 0031766994     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005815503950     Document Type: Article

References (27)

1. Olson ME, Chernik NL, Posner JB: Infiltration of the leptomeninges by systemic cancer: a clinical and pathologic study. Arch Neurol 30: 122-137, 1974
2. Wasserstrom WR, Glass JP, Posner JB: Diagnosis and treatment of leptomeningeal metastases from solid tumors. Cancer 49: 759-722, 1982
3. Piukel D, Woo S: Prevention and treatment of meningeal leukemia in children. Blood 84: 355-366, 1994
4. Steinherz PG: CNS leukemia: Problem of diagnosis, treatment, and outcome. J Clin Oncol 13: 310-313, 1995
5. LoBuglio AF, Saleh MN: Monoclonal antibody therapy of cancer. Crit Rev Oncol/Hematol 13: 271-282, 1992
6. Vallera DA: Immunotoxins: will their clinical promise be fulfilled? Blood 83: 309-317, 1994
7. Hertler AW, Schlossman DM, Borowitz MJ, Poplack DG, Frankel AE: An immunotoxin for the treatment of T-acute lymphoblastic leukemic meningitis: studies in rhesus monkeys. Cancer Immunol Immunother 28: 59-66, 1989
8. Schabet M, Wiethölter H, Meier D: Experimental meningeal neoplasia in nude rats. Neurology 37: 311, 1989 (Abstract)
9. Myklebust AT, Godal A, Fodstad O: Targeted therapy with immunotoxins in a nude rat model for leptomeningeal growth of human small cell lung cancer. Cancer Res 54: 2146-2150, 1994
10. Pastan IH, Archer GE, McLendon RE, Friedman HS, Fuchs HE, Wang QC, Pai LH, Herdon J, Bigner DD: Intrathecal administration of single-chain immunotoxin, LMB-7 (B3(Fv)-PE38), produces cures of carcinomatous meningitis in a rat model. Proc Natl Acad Sci USA 92: 2765-2769, 1995
11. Hall WA, Myklebust A, Godal A, Nesland JM, Fodstad O: In vivo efficacy of intrathecal transferrin-pseudomonas exotoxin A immunotoxin against LOX melanoma. Neurosurgery 34: 649-656, 1994
12. Zovickian J, Youle RJ: Efficacy of intrathecal immunotoxin therapy in an animal model of leptomeningeal neoplasia. J Neurosurg 68: 767-774, 1988
13. Urch CE, George AJT, Stevenson GT, Bolognesi A, Stirpe F, Weller R, Glennie MJ: Intrathecal treatment of leptomeningeal lymphoma with immunotoxin. Int J Cancer 47: 909-915, 1991
14. Walbridge S, Rybak SM: Immunotoxin therapy of leptomeningeal neoplasia. J Neuro-Oncol 20: 59-65, 1994
15. Fulton RJ, Blakey DC, Knowles PP, Uhr JW, Thorpe PE, Vitetta ES: Purification of ricin A1, A2 and B chains and characterization of their toxicity. J Biol Chem 261: 5314-5319, 1986
16. Jansen B, Vallera DA, Jaszcz WB, Nguyen D, Kersey JH: Successful treatment of human acute T-cell leukemia in SCID mice using the anti-CD7-deglycosylated ricin A-chain immunotoxin DA 7. Cancer Res 52: 1314-1321, 1992
17. Thorpe PE, Detre SI, Foxwell BMJ, Brown ANF, Skilleter DN, Wilson G, Forrester JA, Stirpe F: Modification of the carbohydrate in ricin with metaperiodate-cyanoborohydride mixtures. Eur J Biochem 147: 197-206, 1985
18. Stong RC, Youlc RJ, Vallera DA: Elimination of clonogenic T-leukemic cells from human bone marrow using anti-Mr 65,000 protein immunotoxins. Cancer Res 44: 3000-3006, 1984
19. Alley MC, Scudeiro DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH, Boyd MR: Feasability of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 48: 589-601, 1988
20. Schabet M, Ohnseseit P, Buchholz R, Santo-Hoeltje L, Schmidberger H: Intrathecal ACNU treatment of B16 melanoma leptomeningeal metastasis. J Neuro-Oncol 14: 169-175, 1992
21. th Edition. J.B. Lippincott, Philadelphia 1792-1818, 1993
22. Preijers FWMB, De Witte T, Rijke-Schilder GPM, Tax WJM, Wessels JMC, Haanen C, Capel PJA: Human T lymphocyte antigens as target for immunotoxins or complement-mediated cytotoxicity. Scand J Immunol 28: 185-194, 1988
23. Mann JD, Butler AB, Johnson RN, Bass NH: Clearance of macromolecular and particulate substances from the cerebrospinal fluid system of the rat. J Neurosurg 50: 343-348, 1979
24. Preijers FWMB, Tax WJM, DeWitte T, Janssen A, Van der Heijden H, Vidal H, Wessels JMC, Capel PJA: Relationship between internalization and cytotoxicity of ricin A-chain immunotoxins. Brit J Haematol 70: 289-294, 1988
25. Laurent G, Kuhlein E, Casellas P, Canat X, Carayon P, Poncelet P, Correll S, Rigal F, Jansen FK: Determination of sensitivity of fresh leukemia cells to immunotoxins. Cancer Res 46: 2289-2294, 1986
26. Riedel CJ, Muraszko KM, Youle RJ: Diphtheria toxin mutant selectively kills cerebellar Purkinje neurons. Proc Natl Acad Sci USA 87: 5051-5055, 1990
27. Muraszko K, Sung C, Walbridge S, Greenfield L, Dedrick RL, Oldfield EH, Youle RJ: Pharmacukinetics and toxicology of immunotoxins administered into the subarachnoid space in nonhuman primates and rodents. Cancer Res 53: 3752-3757, 1993